share_log

bluebird bio | 3: Initial statement of beneficial ownership of securities-Director Cloonan Michael

bluebird bio | 3: Initial statement of beneficial ownership of securities-Director Cloonan Michael

bluebird bio | 3:首次持股聲明-董事 Cloonan Michael
美股sec公告 ·  06/25 05:16
牛牛AI助理已提取核心訊息
Michael Cloonan, a director and 10% owner of bluebird bio, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated 06/20/2024. The document, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Cloonan does not beneficially own any non-derivative or derivative securities of the company. The form, signed by attorney-in-fact Sydney Gaylin on 06/24/2024, confirms the reporting person's beneficial ownership status and is a standard procedure for individuals in certain positions within publicly traded companies.
Michael Cloonan, a director and 10% owner of bluebird bio, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated 06/20/2024. The document, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Cloonan does not beneficially own any non-derivative or derivative securities of the company. The form, signed by attorney-in-fact Sydney Gaylin on 06/24/2024, confirms the reporting person's beneficial ownership status and is a standard procedure for individuals in certain positions within publicly traded companies.
藍鳥生物公司的董事兼10%股東Michael Cloonan,根據2024年6月20日提交的3號表格向美國證券交易委員會提交了有利物權的初始報告書。該文件是《1934年證券交易法》第16(a)節的要求,表明Cloonan沒有對公司的任何非衍生或衍生證券有利物權。該表格由Sydney Gaylin律師代表此人於2024年6月24日簽署,確認報告人的有利物權狀態,是上市公司內部人士的標準程序。
藍鳥生物公司的董事兼10%股東Michael Cloonan,根據2024年6月20日提交的3號表格向美國證券交易委員會提交了有利物權的初始報告書。該文件是《1934年證券交易法》第16(a)節的要求,表明Cloonan沒有對公司的任何非衍生或衍生證券有利物權。該表格由Sydney Gaylin律師代表此人於2024年6月24日簽署,確認報告人的有利物權狀態,是上市公司內部人士的標準程序。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。